Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Wet AMD
Related studies linked through entity extraction aliases.
Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
NT-101 Topical Ophthalmic Solution in Patients With Wet AMD
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)
- Status
- WITHDRAWN
- Phase
- NA
Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy
- Status
- UNKNOWN
- Phase
- N/A
INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD
- Status
- COMPLETED
- Phase
- PHASE2
Investigates Improvement in Vision Following Switching From Avastin and Macugen Over to Lucentis
- Status
- COMPLETED
- Phase
- N/A
Intravitreal Bevacizumab for Retinal Disorders
- Status
- UNKNOWN
- Phase
- NA